Despite Surging Earnings Sanofi-Aventis is Restructuring and Planning Layoffs
.jpg)
Reuters reports that French drug maker Sanofi-Aventis (S-A) beat analysts second-quarter earning forecasts and that next year’s earnings will likely benefit from increased demand for its new H1NI swine flu vaccine. The company is the largest flu vaccine manufacturer in the world. Yet, despite surging profits, S-A continues to restructure and cut jobs in an effort maintain its stock share price. —and an “impeccable source”— that US managers are in France discussing cuts to American operations. The cuts are expected to be announced during the first week of August. More bad news for the US economy and tens of thousands of American pharmaceutical employees who have already lost their jobs.
Until next time
Good Luck and Good Job Hunting????????
